Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome

Growth hormone (GH) is an essential element for normal growth. However, reports of normal growth without GH have been made in patients who have undergone brain surgery for craniopharyngioma. Normal growth without GH can be explained by hyperinsulinemia, hyperprolactinemia, elevated leptin levels, and GH variants; however, its exact mechanism has not been elucidated yet. We diagnosed a female patient aged 13 with combined pituitary hormone deficiency (CPHD) caused by pituitary stalk interruption syndrome (PSIS). The patient has experienced recurrent hypoglycemic seizures since birth, but reached the height of 160 cm at the age of 13, showing normal growth. She grew another 8 cm for 3 years after the diagnosis, and she reached her final adult height of 168 cm which was greater than the midparental height, at the age of 16. The patient's blood GH and insulin-like growth factor-I levels were consistently subnormal, although her insulin levels were normal. Her physical examination conducted at the age of 15 showed truncal obesity, dyslipidemia, and osteoporosis, which are metabolic features of GH deficiency (GHD). Herein, we report a case in which a PSIS-induced CPHD patient attained her final height above mid parental height despite a severe GHD.

[1]  S. Radovick,et al.  Normal and Aberrant Growth , 2011 .

[2]  M. Phillip,et al.  Growth without growth hormone: growth pattern and final height of five patients with idiopathic combined pituitary hormone deficiency , 2003, Clinical endocrinology.

[3]  P. Mellon,et al.  A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty , 2002, Clinical endocrinology.

[4]  G. Nicholson,et al.  Leptin Inhibits Osteoclast Generation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  A. Tsatsoulis,et al.  A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the "growth without GH" syndrome. , 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[6]  S. Mohan,et al.  Normal growth despite GH, IGF-I and IGF-II deficiency. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[7]  J. Nakae,et al.  Near-Normal Linear Growth in the Setting of Markedly Reduced Growth Hormone and IGF-1 , 1999, Hormone Research in Paediatrics.

[8]  M. Geffner,et al.  The growth without growth hormone syndrome. , 1996, Endocrinology and metabolism clinics of North America.

[9]  P. Brazeau,et al.  Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects. , 1989, Metabolism: clinical and experimental.

[10]  N. Bersch,et al.  GROWTH WITHOUT GROWTH HORMONE: EVIDENCE FOR A POTENT CIRCULATING HUMAN GROWTH FACTOR , 1986, The Lancet.

[11]  G. Costin,et al.  Hypothalamic-pituitary function in children with optic nerve hypoplasia. , 1985, American journal of diseases of children.

[12]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[13]  H. Bucher,et al.  Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. , 1983, The New England journal of medicine.

[14]  A. Frantz,et al.  Normal growth with subnormal growth-hormone levels. , 1968, The New England journal of medicine.